Table 4.

Causes of death for patients with and without cGVHD

No chronic
GVHD
(523 patients)
Chronic
GVHD
(173 patients)
Total
(696 patients)
Disease progression (%) 88 (60) 14 (31) 102  (53) 
Transplant-related causes (%) 58 (40) 31 (69) 89  (47)  
 Bacterial pneumonia  
 HCMV interstitial pneumonia  
 Bacterial infection 10  
 Fungal infection  
 Viral infection  
 EBV-PTLD  
 Encephalitis  
 ARDS  
 Idiopathic interstitial pneumonia  
 Autoimmune hemolytic anemia  
 Thrombotic thrombocytopenic
purpura 
 
 Liver failure  
 Renal failure  
 Cardiac insufficiency  
 Multiorgan failure  
 Hemorrhage 10  
 cGVHD 11  
Total 146 45 191 
No chronic
GVHD
(523 patients)
Chronic
GVHD
(173 patients)
Total
(696 patients)
Disease progression (%) 88 (60) 14 (31) 102  (53) 
Transplant-related causes (%) 58 (40) 31 (69) 89  (47)  
 Bacterial pneumonia  
 HCMV interstitial pneumonia  
 Bacterial infection 10  
 Fungal infection  
 Viral infection  
 EBV-PTLD  
 Encephalitis  
 ARDS  
 Idiopathic interstitial pneumonia  
 Autoimmune hemolytic anemia  
 Thrombotic thrombocytopenic
purpura 
 
 Liver failure  
 Renal failure  
 Cardiac insufficiency  
 Multiorgan failure  
 Hemorrhage 10  
 cGVHD 11  
Total 146 45 191 

χ2 = 11.76, P = .0006 for the comparison of causes of death (disease progression versus transplant-related cause) in subjects with and without cGVHD.

For the 11 patients with cGVHD reported as the main cause of death, the ultimate cause of death was bronchiolitis obliterans in 4 cases, HCMV interstitial pneumonia in 1 case, bacterial pneumonia in 1 case, other bacterial infections in 3 cases, hemorrhagic complications in 1 case, and multiorgan failure in 1 case. HCMV indicates human cytomegalovirus; EBV-PTLD, Epstein-Barr virus–related posttransplantation lymphoproliferative disease; ARDS, acute respiratory distress syndrome.

or Create an Account

Close Modal
Close Modal